Antipsoriatic / Keratolytic
Pregnancy: Caution — theoretical mutagenicity concern; limit use to small areas
Coal Tar
Brand names: Alphosyl HC, Capasal, Clinitar, T/Gel Shampoo
Adult dose
Dose: Apply OD–BD to affected skin. Shampoo: 2–3 times weekly. Coal tar paste: applied to plaques, covered with tubular bandages overnight.
Route: Topical
Frequency: OD–BD (cream/gel); as directed for shampoo/paste
Max: Apply as directed; avoid extensive use on large areas
For psoriasis, seborrhoeic dermatitis, and chronic plaque psoriasis. Stains clothing and bedding. Avoid broken or inflamed skin.
Paediatric dose
Route: Topical
Frequency: OD–BD
Max: Age-dependent formulation
Concentration: Various concentrations (0.5%–12%) Cream/paste/ml
Safe from birth for seborrhoeic dermatitis (lower concentrations). Higher strengths for older children with plaque psoriasis. Avoid on face.
Dose adjustments
Renal
N/A
Hepatic
N/A
Clinical pearls
- Staining: advise old clothing and bedding; avoid sun/UV treatment for 24h after application to reduce photosensitivity
- NICE NG220: coal tar second-line emollient in psoriasis
- Combine with UVB phototherapy in Goeckerman regime for recalcitrant psoriasis
- T/Gel shampoo: licensed OTC for seborrhoeic dermatitis and scalp psoriasis
Contraindications
- Acute inflammation of psoriasis (erythroderma)
- Open wounds
- Genital area
Side effects
- Staining of skin and clothing
- Folliculitis
- Photosensitivity (avoid UV immediately after application)
- Contact sensitisation
- Strong smell
Interactions
- Photosensitising agents — additive photosensitivity
Monitoring
- Skin irritation
- Photosensitivity reactions
Reference: BNFc; BNF; NICE NG220 Psoriasis; BAD Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD